BioSpace News Archive

Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel therapies for patients suffering from acute respiratory conditions, announced today that it has completed formation of its scientific advisory board.

Spine Industry Leader Brings Decades of Experience Introducing New Products Designed to Improve Patient Care

La Jolla, California--(Newsfile Corp. - January 13, 2021) - Tryp Therapeutics, a leading pharmaceutical company focused on identifying and developing clinical-stage compounds for diseases with high unmet medical needs, announced today it has been invited to present at two upcoming industry conferences in January and February 2021.

Vancouver, British Columbia--(Newsfile Corp. - January 13, 2021) - BioHarvest Sciences Inc. (CSE: BHSC) (the “Company” or “BioHarvest”) announces that it has created a new board of scientific advisors to assist the Company in capitalizing on its proprietary BioFarming technology.

Alkame Holdings, Inc. (OTCPINK: ALKM ), a publicly-traded health and wellness technology holding company, through its Alkame Medical division, is pleased to announce that it is now set up to offer premium disposable personal protection 3 ply and 5 ply masks to its lineup of PPE Product offerings for distribution.

Promaxo, Inc., the medical imaging, robotics, and AI technology company, and Huami Corp. announced closing an investment round of $4.17M led by Huami.

Blue Cross Blue Shield of Massachusetts (“Blue Cross”) has partnered with The Dimock Center to produce a new public health messaging video to support the COVID-19 vaccination effort.

--Study demonstrates the efficacy and therapeutic potential of select ionizable lipid nanoparticles for delivering mRNA to treat genetic diseases before birth--

LabMinds, Inc., a next-generation robotics company focused on solution preparation, announces that Anita Santos has been named as Vice President of Marketing.

UroGen Pharma Ltd. (Nasdaq: URGN), today announced a strategic three-year collaboration agreement to advance combinatorial intravesical immunotherapy, which is delivered directly into the bladder, for the treatment of high-grade non-muscle invasive bladder cancer